These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35033212)

  • 1. Theranos and the scientific community: at the bleeding edge.
    The Lancet
    Lancet; 2022 Jan; 399(10321):211. PubMed ID: 35033212
    [No Abstract]   [Full Text] [Related]  

  • 2. Holmes verdicts prompt questions over justice for patients.
    Jaffe S
    Lancet; 2022 Jan; 399(10321):224-225. PubMed ID: 35033214
    [No Abstract]   [Full Text] [Related]  

  • 3. Lessons from Theranos - Restructuring Biomedical Innovation.
    Das RK; Drolet BC
    J Med Syst; 2022 Apr; 46(5):25. PubMed ID: 35378645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Scientific misconduct: A major threat for medical research].
    Barde F; Peiffer-Smadja N; de La Blanchardière A
    Rev Med Interne; 2020 May; 41(5):330-334. PubMed ID: 32107052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are hospitals next in line? Government investigators probing relationships between physicians, devicemakers may soon train sights on hospitals.
    Taylor M
    Mod Healthc; 2006 Aug; 36(32):24-6. PubMed ID: 16958280
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of federal programs in the transfer of biomedical technology.
    Phillips SJ
    Artif Organs; 2004 May; 28(5):432-6. PubMed ID: 15113335
    [No Abstract]   [Full Text] [Related]  

  • 7. Slippery business: the trade in adulterated olive oil.
    Mueller T
    New Yorker; 2007 Aug; ():38-45. PubMed ID: 17715510
    [No Abstract]   [Full Text] [Related]  

  • 8. Bioterror and "bioart"--a plague o' both your houses.
    Annas GJ
    N Engl J Med; 2006 Jun; 354(25):2715-20. PubMed ID: 16790708
    [No Abstract]   [Full Text] [Related]  

  • 9. Suspected research fraud: difficulties of getting at the truth.
    White C
    BMJ; 2005 Jul; 331(7511):281-8. PubMed ID: 16052022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twenty-five years of health law through the lens of the civil false claims act.
    Krause JH
    Ann Health Law; 2010; 19(1 Spec No):13-7. PubMed ID: 21495540
    [No Abstract]   [Full Text] [Related]  

  • 11. Theranos founder counters fraud charges in federal trial.
    Jaffe S
    Lancet; 2021 Nov; 398(10315):1952. PubMed ID: 34838165
    [No Abstract]   [Full Text] [Related]  

  • 12. Price-fixing allegations. Orthopedic devicemakers targeted.
    Mantone J
    Mod Healthc; 2006 Aug; 36(32):25. PubMed ID: 16958281
    [No Abstract]   [Full Text] [Related]  

  • 13. Counterfeit pharmaceuticals: in the line of fire. Dora Akunyili interviewed by Peter Aldhous.
    Akunyili D
    Nature; 2005 Mar; 434(7030):134. PubMed ID: 15758967
    [No Abstract]   [Full Text] [Related]  

  • 14. The Theranos phenomenon, scientific transparency and freedom of speech.
    Lackner KJ; Gillery P; Lippi G; Melichar B; Schlattmann P; Tate JR; Plebani M
    Clin Chem Lab Med; 2016 Sep; 54(9):1403-5. PubMed ID: 27442369
    [No Abstract]   [Full Text] [Related]  

  • 15. Theranos phenomenon - Part 5: Theranos' presentation at the American Association for Clinical Chemistry Annual Conference 2016.
    Diamandis EP; Plebani M
    Clin Chem Lab Med; 2016 Oct; 54(10):e313-4. PubMed ID: 27574855
    [No Abstract]   [Full Text] [Related]  

  • 16. Science, fraud and the Baltimore case.
    Bernstein J
    Commentary; 1998 Dec; 106(6):40-4. PubMed ID: 15986525
    [No Abstract]   [Full Text] [Related]  

  • 17. Fraud and misconduct in scientific research: a definition and procedures for investigation.
    Catano VM; Turk J
    Med Law; 2007 Sep; 26(3):465-76. PubMed ID: 17970246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Travels on the fraud circuit.
    Lewin B
    Cell; 1989 May; 57(4):513-4. PubMed ID: 2720779
    [No Abstract]   [Full Text] [Related]  

  • 19. Importance of technical operations: lessons from evolving biotherapeutics production methods.
    Jaluria P; Adams DN
    Trends Biotechnol; 2009 Nov; 27(11):612-4. PubMed ID: 19765844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of being earnest in post-publication review: scientific fraud and the scourges of anonymity and excuses.
    Stebbing J; Sanders DA
    Oncogene; 2018 Feb; 37(6):695-696. PubMed ID: 29035386
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.